Protective effects of probiotic Lactobacillus rhamnosus IMC501 in mice treated with PhIP.
- 2014-03-28
- Journal of Microbiology and Biotechnology 24(3)
- L. Dominici
- M. Villarini
- F. Trotta
- E. Federici
- G. Cenci
- M. Moretti
- PubMed: 24346468
- DOI: 10.4014/JMB.1309.09072
Abstract
The aim of the present study was to investigate the antigenotoxic properties of the probiotic Lactobacillus rhamnosus IMC501; DNA damage was induced by one representative food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Mice were treated orally with suspensions of lactobacilli for 10 days before administration of food mutagen. During the treatment, the abundance of lactobacilli in feces, as assessed by qPCR analysis, increased, whereas β-glucuronidase and N-acetyl-β-glucosaminidase activities decreased. The extent of DNA damage was measured in colon and liver cells by comet assay. In colonocytes, diet supplementation with IMC501 resulted in a significant inhibition of DNA damage induced by PhIP. The results obtained in this in vitro study suggest that Lactobacillus rhamnosus IMC501 used as a dietary supplement can provide a useful integration of antimutagen food components of the normal diet, which are generally lower than the protective level.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Lactobacillus rhamnosus IMC 501 | Increased Fecal Lactobacilli Abundance | Beneficial | Moderate |
Lactobacillus rhamnosus IMC 501 | Reduced Beta-Glucuronidase Activity | Beneficial | Moderate |
Lactobacillus rhamnosus IMC 501 | Reduced DNA Damage | Beneficial | Moderate |
Lactobacillus rhamnosus IMC 501 | Reduced N-acetyl-β-glucosaminidase Activity | Beneficial | Moderate |